Skip to main content

Table 4 Univariate analysis of patient characteristics associated with 30 day all-cause mortality

From: Molecular epidemiology and outcome of carbapenem-resistant Enterobacterales in Saudi Arabia

Parameter OR 95% CI p-value
Age (years) 1.02 (1.01–1.04) 0.01
Charlson comorbidity index 1.20 (1.07–1.33) 0.001
Pitt bacteremia score 1.32 (1.15–1.50) < 0.0001
APACHE II score 0.99 (0.95–1.02) 0.43
CLABSI 2.74 (1.21–6.22) 0.02
HAP/VAP 2.31 (1.15–4.64) 0.02
Complicated UTI 0.50 (0.22–1.12) 0.09
Complicated intra-abdominal infection 0.37 (0.14–1.03) 0.06
Skin and soft tissue infection 0.75 (0.26–2.17) 0.60
Joint/bone infection < 0.001 (< 0.001–> 999.99) 0.98
Primary bacteremia (source unidentified) 2.17 (0.75–6.30) 0.15
CRE bacteremia 2.75 (1.45–5.21) 0.002
NDM 1.49 (0.67–3.31) 0.32
OXA48 1.35 (0.68–2.71) 0.39
Received CAZ-AVI 0.75 (0.40–1.40) 0.37
Cardiac disease 1.69 (0.81–3.55) 0.16
Diabetes Mellitus 2.02 (1.08–3.79) 0.03
Non-hematological malignancy 1.30 (0.22–3.37) 0.44
Hematological malignancy 0.86 (0.67–2.49) 0.83
Immunosuppressive medication 1.10 (0.52–2.32) 0.81
  1. OR odds ratio, CI confidence interval